Key result
Multimodal monitoring outperforms single coagulation assays for tailored anticoagulation in V-V ECMO.
Why the study?
High-quality data to personalize anticoagulation management in ECMO are lacking, resulting in high practice variability among centers.
Answers are grounded in this paper and cite their sources.
Because no single coagulation assay exclusively predicts bleeding or thrombotic risk during V-V ECMO, this review proposes a personalized, multimodal monitoring protocol combining point-of-care, chromogenic, coagulometric, and viscoelastic testing to optimize anticoagulation management.
(1) Background: Extracorporeal membrane oxygenation (ECMO) is a complex procedure affecting both the risk of thrombosis and bleeding. High-quality data to personalize anticoagulation management in ECMO are lacking, resulting in a high variability in practice among centers. For this reason, we review coagulation methods and monitoring and share a pragmatic proposal of coagulation management, as performed in our high-volume ECMO Referral Centre; (2) Methods: We revised the anticoagulation options and monitoring methods available for coagulation management in ECMO through PubMed search based on words including "anticoagulation," "coagulation assays," "ECMO," "ELSO," and "ISTH"; (3) Results: Actual revision of the literature was described as our routine practice regarding ECMO anticoagulation and monitoring; (4) Conclusions: No coagulation test is exclusively predictive of bleeding or thrombotic risk in patients undergoing ECMO support. An approach that allows for a tailored regimen of anticoagulation (regardless of agent used) and monitoring is mandatory. To accomplish this, we propose that the titration of anticoagulation therapies should include multiple laboratory tests, including anti-Xa, aPTT, ACT, viscoelastic tests, AT levels, platelet count, fibrinogen, and FXIII levels. Anticoagulation regimens should be tailored to a specific patient and personalized based on this complex array of essays.
No takes yet. Share an insight, caveat, or question.
Rodrigues et al. (2024) conducted a review in Veno-venous extracorporeal membrane oxygenation (V-V ECMO) for respiratory failure. Multimodal anticoagulation management and monitoring protocol (unfractionated heparin or bivalirudin titrated via anti-Xa, aPTT, ACT, dTT, antithrombin levels, and viscoelastic testing) was evaluated on Prevention and management of thrombotic and bleeding events during V-V ECMO support. Tailored anticoagulation in V-V ECMO requires multimodal monitoring combining anti-Xa, aPTT, ACT, antithrombin, and viscoelastic tests rather than relying on any single coagulation assay.
Synapse has enriched 10 related papers. Consider them for comparative context: